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Abstract 
Background: The circumsporozoite protein is the most abundant polypeptide expressed by sporozoites, the malaria 
parasite stage capable of infecting humans. Sporozoite invasion of mosquito salivary glands prior to transmission 
is likely mediated by a receptor/ligand‑like interaction of the parasites with the target tissues, and the amino (NH2)‑
terminal portion of CSP is involved in this interaction but not the TSR region on the carboxyl (C)‑terminus. Peptides 
based on the NH2‑terminal domain could compete with the parasites for the salivary gland receptors and thus inhibit 
penetration.
Methods: Peptides based on the NH2‑terminus and TSR domains of the CSP from avian or human malaria para‑
sites, Plasmodium gallinaceum and Plasmodium falciparum, respectively, were expressed endogenously in mosquito 
haemolymph using a transient (Sindbis virus‑mediated) or stable (piggyBac‑mediated transgenesis) system.
Results: Transient endogenous expression of partial NH2‑terminus peptide from P. falciparum CSP in P. gallina-
ceum‑infected Aedes aegypti resulted in a reduced number of sporozoites in the salivary glands. When a transgenic 
approach was used to express a partial CSP NH2‑terminal domain from P. gallinaceum the number of sporozoites in 
the salivary glands did not show a difference when compared to controls. However, a significant difference could be 
observed when mosquitoes with a lower infection were analysed. The same result could not be observed with mos‑
quitoes endogenously expressing peptides based on the TSR domain from either P. gallinaceum or P. falciparum.
Conclusion: These results support the conclusion that CSP partial NH2‑terminal domain can be endogenously 
expressed to promote a competition for the receptor used by sporozoites to invade salivary glands, and they could 
be used to block this interaction and reduce parasite transmission. The same effect cannot be obtained with peptides 
based on the TSR domain.
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Background
Malaria parasites have a complex developmental cycle 
in both the vertebrate and vector mosquito hosts. The 
sporozoites are the most versatile invasive stage of the 
parasite and are unique in having the ability to invade 
two types of cells, their primary targets in their verte-
brate hosts and those of the mosquito salivary glands 
[1]. Furthermore, target-cell specificity supports the 
hypothesis that the localization and penetration of mos-
quito salivary glands by sporozoites is mediated by recep-
tors [2–5]. Two mosquito proteins, circumsporozoite 
binding protein (CSPBP) and saglin, were identified as 
receptors for sporozoites and these interact with the 
parasite-expressed circumsporozoite protein (CSP) and 
thrombospondin-related anonymous protein (TRAP), 
respectively [4, 5]. Merozoite apical erythrocyte-binding 
ligand (MAEBL) is another proposed sporozoite ligand 
involved in attachment and invasion of mosquito salivary 
glands [6], however, no receptor has been characterized 
yet.
CSP is the predominant sporozoite surface antigen and 
important for mediating recognition and invasion of the 
salivary glands (as reviewed [7, 8]). It is expressed by a 
single copy gene [9], and has a large central immuno-
dominant domain comprising tandem repeats of small 
peptides. The amino-(NH2) terminus comprises a 
domain of hydrophobic amino acid that makes up the 
secretory signal peptide, and a pentapeptide (KLKQP) 
designated Region I, that contains a proteolytic cleav-
age site. Cleavage is required for vertebrate hepatocyte 
cell invasion, but is not necessary for salivary gland 
infection in the mosquito host [10, 11]. Furthermore, 
the NH2-terminus together with the repeat domain is 
responsible for sporozoite development and Plasmodium 
berghei mutants lacking these regions do not produce 
free sporozoites [12]. The carboxyl-(C) terminus, which 
has sequence similarity to the thrombospondin type-1 
repeat (TSR) superfamily, has an 18-amino acid sequence 
(EWSXCXVTCGXG(V/I)XXRX(K/R) designated Region 
II [13–15], and a putative glycosylphosphatidylinositol 
(GPI) anchor attachment site. Both Regions I and II are 
conserved highly among Plasmodium species [16].
Plasmodium falciparum CSP binds with greater avid-
ity to the medial lobe and distal portions of the lat-
eral lobes of Anopheles stephensi salivary glands than 
any other mosquito organs that are in contact with the 
haemolymph, and these lobes are invaded preferentially 
by sporozoites [17]. A synthetic peptide encompassing 
Region I, plus the additional five amino acids immediately 
adjacent to the amino-end of the endogenous sequence, 
inhibits CSP binding to salivary glands [17]. In addition, 
synthetic peptides encompassing P. falciparum Region 
I inhibit by 80  % sporozoite invasion of salivary glands 
[18]. Mutant sporozoites expressing a CSP in which 
Region I is deleted invade salivary glands with a 10–15 % 
lower efficiency compared with controls, and mutants 
with a complete N-terminal deletion have ten-fold fewer 
salivary gland sporozoites compared with controls [11]. 
In contrast, P. berghei mutant sporozoites expressing a 
P. falciparum CSP lacking Region I showed no impair-
ment of motility or infectivity in the vector host, how-
ever, disruption of Region II interfered with motility and 
impaired sporozoite invasion of salivary gland [19].
Transient (recombinant Sindbis virus) and stable (pig-
gyBac-mediated mosquito transformation) expression 
systems were used to study competition between differ-
ent peptides from Plasmodium gallinaceum and P. falci-
parum based on NH2-terminus or TSR domains of CSP 
and conspecific sporozoites for receptors in the salivary 
gland of Aedes aegypti. The data presented here shows 
that only NH2-terminal peptides interfere with sporozo-
ite penetration of mosquito salivary glands. Furthermore, 
a heterologous P. falciparum CSP partial NH2-terminus 
peptide also can block P. gallinaceum sporozoite invasion 
of the Ae. aegypti salivary glands. These results support 
the conclusion that the partial NH2-terminus peptides 
from both P. gallinaceum and P. falciparum may act as 
ligands in the invasion of mosquito salivary glands, and 
the possibility of using the peptides to prevent parasite 
transmission.
Methods
Mosquitoes and maintenance of Plasmodium gallinaceum 
life cycle
The Ae. aegypti Higgs white-eyed strain [20] was main-
tained in the insectary at Universidade de São Paulo, 
Parasitology Department at 27  ±  2  °C, 80  % relative 
humidity, 12/12 h day/night, with access ad  libitum to a 
10 % sucrose solution in water. Anesthetized mice were 
used when required for blood feeding. Larvae were fed 
with powdered fish food (Tetramin, Blacksburg, VA, 
USA). P. gallinaceum were maintained as described [21]. 
Mosquitoes were fed on chickens infected with P. gallina-
ceum (strain 8A, obtained from A. Krettli, René Rachou 
Institute of Research, FIOCRUZ, MG, Brazil). Infection 
was determined by the presence of sporozoites in the sal-
ivary glands and infected females were fed thereafter on 
uninfected chickens.
Sindbis virus cloning and infectious virus production
Peptides designated pNH2-T, RTSR and pTSR, encom-
pass NH2-terminus portion of CSP, the repeat plus a 
partial portion of TSR domain and only a partial por-
tion of TSR domain, respectively (Fig. 1). The prefix ‘Pg’ 
or ‘Pf ’ is added before each peptide to differentiate P. 
gallinaceum from P. falciparum CSP, respectively. The 
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gene amplification (PCR) of the coding sequences of the 
recombinant peptides was done in two steps so as to 
include a region 72 base-pairs (bp) in length encoding 
the Maltase-like I signal peptide (to direct recombinant 
peptides to mosquito haemolymph) [22] at the 5′-end 
of the fragments. In the first PCR, primers specific for 
each fragment added the 3′-end of the Maltase-like I sig-
nal peptide, followed by a second PCR with the general 
primer pair to complete the Maltase-like I signal peptide 
5′-end with XbaI/ApaI and XbaI restriction enzyme site 
sequences for directional cloning. All primer sequences 
used to build the constructs listed in Additional file 1.
After the two-step amplification, the fragments were 
cloned into pGEM-T (Promega) and XbaI digestion was 
used to recover the final constructs, which then were 
sub-cloned into the Sindbis virus expression plasmid, 
TE/3′2  J later (Additional file  2), generating Sin-PgpNT 
and Sin-PfpNT representing the peptides encompassing 
NH2-terminus CSP of P. gallinaceum and P. falciparum, 
respectively, and Sin-PgRTSR (P. gallinaceum) and Sin-
PfRTSR and Sin-PgpTSR (P. falciparum) representing 
peptides encompassing the TSR domain of CSP.
Plasmids containing Sin-PgpNT, Sin-PfpNT, Sin-
PgRTSR, Sin-PfRTSR, or Sin-PgpTSR were linearized 
with XhoI and transcription in vitro was performed with 
AmpliScribe™ T7-Fash™ (Epicentre) kit. Transcribed 
RNA was transfected with Lipofectamine™ Reagent 
(Invitrogen) in BHK-21 cells, viruses were transferred to 
C6/36 cells 72 h later, harvested at four days post-infec-
tion and stored in −80 °C until used. Aliquots of viruses 
were titrated using C6/36 cells through an end-point 
assay [23].
Transgene assembly and Aedes aegypti genetic 
transformation
A PgpNT fragment was amplified with primers designed 
to add the BglII and NotI restriction sites for directional 
cloning into the vector pSLfa [AeVg] [24]. This plasmid 
Fig. 1 Partial NH2‑terminus and partial TSR peptides endogenously expressed from Plasmodium gallinaceum and Plasmodium falciparum. a Sche‑
matic representation of circumsporozoite protein and endogenously‑expressed peptides. The open bricked block represents the signal peptide; the 
red block represents the NH2‑terminus; the light gray block represents the conserved motif Region I; the striped block represents the tandem repeats; 
the blue block represents the TSR domain; the gray block represent the region II motif and the dotted block the putative GPI anchor. b Alignment of 
amino acid sequences of endogenously‑expressed peptides from P. gallinaceum (PG) and P. falciparum (PF) CSPs. Key: red, partial NH2‑terminal; light 
gray, Region I; asterisks, conserved amino acids; underlined, tandem repeats; blue, partial TSR; and dark gray, Region II
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has the Ae. aegypti Vitellogenin I (VgI) gene promoter 
for blood-meal induced expression of the peptides in 
the haemolymph [24]. The FOW_BglII and REV_NotI 
primers (Additional file  1) were used to amplify these 
fragments from the Sin-PgpNT plasmid. After amplifi-
cation, the product was cloned first into the TOPO TA 
cloning (Invitrogen), sequenced and sub-cloned into 
the pSLfa[AeVg] plasmid. The cassette [AeVg-PgpNT] 
was excised using AscI and sub-cloned into pBac 3XP3-
eGFPafm. The resulting vector generated is designated 
pBac[3XP3-eGFP-AeVg-PgpNT] (Additional file  2). 
Transgenic Ae. aegypti lines were generated by injecting 
preblastoderm embryos with a mixture of the donor plas-
mid pBac[3XP3-eGFP-AeVg-PgpNT] (300  µg/µL) and 
the pBac helper plasmid (200  µg/µL) using procedures 
described previously [25].
RT‑PCR
Whole-body total RNA was isolated from Sindbis virus-
infected and transgenic Ae. aegypti with TRIzol (Inv-
itrogen) and treated with DNAse I (Invitrogen). The 
amplification of diagnostic products was done using 
the OneStep RT-PCR kit (Qiagen) and primers listed in 
Additional File 1. The reaction mixture was incubated 
at 50 °C for 30 min and 95 °C for 15 min. Amplification 
conditions were 94 °C for 1 min followed by 30 cycles of 
94 °C for 1 min, 60 °C for 1 min and 72 °C for 1 min and a 
final step of 10 min at 72 °C.
Salivary gland infection assay in dsSindbis‑infected Aedes 
aegypti
Four day-old adult females were injected with 0.5 μL of 
a solution containing 106 50  % tissue culture infective 
dose (TCID50  %) Sin-PfpNT, Sin-PgRTSR, Sin-PfRTSR 
and Sin-PgpTSR and control Sin-EGFP (recombinant 
Sindbis virus expressing EGFP) infectious virus. After 3 
days, mosquitoes were allowed to feed on P. gallinaceum-
infected chickens (8–11  % parasitemia) and only fully-
engorged females were used in the experiments. Salivary 
glands pairs were dissected on the 8th day after the infec-
tious blood meal according to P. gallinaceum infection 
profile [26] (corresponding to 11th day after dsSind-
bis infection) and individually homogenized in 10 µL of 
phosphate-buffered saline (PBS), placed in a haemocy-
tometer and sporozoite numbers determined by phase-
contrast microscopy.
Salivary gland infection assay in transgenic Aedes aegypti
Transgenic and wild-type female Ae. aegypti were fed on 
P. gallinaceum-infected chickens with an 8–11 % parasi-
taemia. Five days after the first blood feeding, a second 
blood meal using healthy mice was offered to main-
tain the expression from the blood meal-induced VgI 
gene promoter driving the recombinant CSP peptides 
[27]. Sporozoite number was determined as described 
previously.
Statistical analysis
The data were analysed with GraphPad InStat version 
3.00 Software and Mann–Whitney and unpaired t test 
was used to assess the statistical significance of the dif-
ferences between control and experimental groups, a p 
value of <0.05 was considered statistically significant.
Results
dsSindbis virus production in BHK21 cells and mRNA 
expression in dsSindbis virus infected mosquitoes
The infectivity of the experimental and control recom-
binant viruses was verified by the observation of cyto-
pathic effects and EGFP expression in BHK-21 cells 
(Fig. 2a). Examination of control BHK-21 cells monolay-
ers by phase contrast microscopy shows star-shaped 
cells with a fusiform appearance and a confluent mon-
olayer of ~80  %. Cytopathic effects were recognized on 
BHK-21 monolayers 24 h after dsSindbis infection. Spe-
cifically, it was observed loss of cell structure (round 
cells) and detachment from surface of the flask. Also, 
fluorescence microscopy shows that the EGFP could be 
detected in most BHK-21 cells infected with Sindbis-
GFP, with stronger signals in the round cells. RT-PCR 
analyses verified that females injected intrathoracically 
with Sin-PfpNT, Sin-PgRTSR, Sin-PfRTSR, Sin-PgpTSR 
and the control Sin-EGFP viral particles were accumulat-
ing the respective transcripts on the 11th day post-viral 
infection, which is the day the P. gallinaceum challenge 
was performed (Fig.  2b). Although Sin-PgpNT-infected 
mosquitoes showed the expected amplification product, 
the accumulated level of transcripts appeared lower than 
what was observed in the other virus-injected groups. 
Additionally, a smaller, unanticipated amplification prod-
uct was detected in Sin-PgpNT-injected mosquitoes 
(Fig.  2b), thus PgpNT peptide expression was analysed 
using a transgenic approach.
Plasmodium gallinaceum infection in Aedes aegypti 
transiently expressing CSP peptides
Sindbis viruses were injected into mosquitoes to endog-
enously express the CSP peptides to promote competi-
tion for the salivary gland receptors. The numbers of 
sporozoites recovered from salivary glands of mosquitoes 
injected with Sin-PgRTSR, Sin-PfRTSR and Sin-PgpTSR 
viral particles were similar to those recovered from the 
control group injected with dsSin-EGFP, and no statisti-
cal differences were observed (p = 0.234, 0.111 and 0.355, 
respectively) (Fig. 3). However, expression of Sin-PfpNT 
in infected mosquitoes resulted in a 31.5 % reduction of 
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mean sporozoites numbers when compared with controls 
(p =  0.018). The results demonstrate that the dsSindbis 
virus system is capable of expressing CSP derivative pep-
tides, and that partial CSP NH2-terminal peptides from P. 
falciparum are capable of blocking P. gallinaceum infec-
tion of Ae. aegypti salivary glands while peptides based 
on TSR domains from either P. gallinaceum or P. falci-
parum are not (Figs. 2, 3). These data are consistent with 
competition between the peptides and sporozoites for a 
reception on the mosquito salivary glands.
Analyses of transgenic Aedes aegypti endogenously 
expressing Plasmodium gallinaceum partial NH2‑terminus 
CSP peptide
Since the PgpNT peptide could not be tested using the 
dsSindbis system, a transgenic approach was used to evalu-
ate it. Three independent transgenic lines (P#1, P#4 and 
F#8) carrying pBac-PgpNT were recovered following injec-
tion of 1098 Ae. aegypti embryos, standard rearing and 
screening procedures. From the embryos microinjected, 
111 larvae were recovered (10 % eclosion rate) but only 62 
Fig. 2 Sindbis virus production in BHK21 cells and mRNA expression in dsSindbis virus infected mosquito. a Light microscope observation of a 
BHK21 cell monolayer (top left panel), BHK21 stably transfected with Sin‑PfRTSR (top right panel) or dsSin‑EGFP (bottom left panel) and fluorescence 
microscopy of BHK‑21 transfected with dsSin‑EGFP (bottom right panel). b Detection of transcript from dsSindbis virus‑infected mosquitoes. Total 
RNA samples were extracted from female mosquitoes eleven days after thoracic microinjection with each of the Sin‑EGFP, Sin‑PgpNT, Sin‑PgRTSR, 
Sin‑PgpTSR, Sin‑PfpNT, Sin‑PfRTSR viral particles, and used in a RT‑PCR reaction. The same RNA samples were also analysed by actin‑specific primers 
(Additional file 1). Abbreviations: C negative control (without template)
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made it to adulthood and provided fertile families. From the 
progeny of these families, 3248 larvae were analysed and 77 
were positive for EGFP, 10 for P#1, 66 for P#4 and 1 for F#8. 
All EGFP-positive larvae had fluorescence in their eyes and 
neural tubes but not in the anal papillae, and only in the eyes 
of pupae and adults (Fig. 4a).
Fig. 3 Plasmodium gallinaceum infection of individual dsSindbis‑infected and control mosquitoes. Aedes aegypti females were injected intrathoraci‑
cally with Sin‑PfpNT, Sin‑PgRTSR, Sin‑PfRTSR, Sin‑PfpTSR and control Sin‑EGFP, and were fed three days later on P. gallinaceum‑infected chickens. 
Salivary glands were dissected eight days after infected blood meal and sporozoite counted using phase‑contrast microscopy. Solid circles (control 
Sin‑EGFP) and squares (Sin‑PfpNT, Sin‑PgRTSR, Sin‑PfRTSR, Sin‑PfpTSR) represent individual mosquitoes with sporozoites detected in their salivary 
glands. The horizontal bars represent the median. A p value of <0.05 was considered statistically significant
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Transgene insertions were confirmed by diagnostic 
gene amplification using primers specific for the PgpNT 
sequence (Additional file  1). The expected PgpNT frag-
ments were amplified from P#1 and P#4 genomic DNA, 
but a fragment larger than expected was amplified 
from the F#8 line (Fig. 4b). RT-PCR on pools of 10 P#1 
females verified transcript presence and accumulation of 
the PgpNT transgene product at 24  h post-blood meal 
(hPBM) but not in samples prepared from mosquitoes 48 
and 72 h PBM. This is consistent with the expression pro-
file of the endogenous VgI gene. No cDNA amplification 
was detected in the P#4 line (Fig. 4c). Both lines F#8 (no 
Fig. 4 Generation, characterization and Plasmodium gallinaceum infections of pBac[3XP3‑eGFP‑AeVg‑PgpNT] transgenic mosquitoes. a EGFP 
fluorescence in both eyes of larvae, pupae and adults of transgenic mosquitoes (T) but not in wild‑type controls (WT). Only in larvae EGFP could 
be detected in the neural tube. b Genomic DNA was extracted from transgenic lines pBac‑PgpNT P#1, P#4 and F#8 and used for PCR with specific 
primers for the PgpNT fragment. c Detection of transgenic transcript from pBac‑PgpNT P#1 mosquitoes. Total RNA was extracted from non‑blood 
fed (NBF), 24, 48 and 72 h post‑blood meal females mosquitoes and used on a RT‑PCR reaction with specific primers for PgpNT sequence. The same 
RNA samples were also analysed by vitellogenin (Vg) and actin (Act) gene‑specific primers (Additional file 1). d Transgenic pBac‑PgpNT P#1 and wild‑
type adult females were fed in P. gallinaceum‑infected chickens, five days later a second blood meal with healthy mice was offered. Salivary glands 
were dissected eight days after infected blood meal and sporozoite counted using phase‑contrast microscopy. Solid circles and squares represent 
individual wild‑type and transgenic mosquitoes respectively, with sporozoites detected in their salivary glands. The horizontal bars represent the 
median, a p value of <0.05 was considered statistically significant
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diagnostic gene fragment of the expected size) and P#4 
(unexpected expression profile) were discarded and only 
P#1 was used in subsequent experiments.
Plasmodium gallinaceum infection in Aedes aegypti 
pBac‑PgpNT P#1 transgenic mosquitoes
In order to evaluate the capacity of PgpNT peptide to com-
pete with sporozoites for salivary gland receptors, trans-
genic P#1 and wild-type Ae. aegypti females were fed on 
chickens with 8–11  % P. gallinaceum parasitaemia. The 
numbers of sporozoites recovered from salivary glands of 
challenged P#1 individual transgenic mosquitoes did not 
differ from the wild-type (p < 0.2097). Previous experiments 
showed that P. gallinaceum infection in Ae. aegypti (Higgs 
strain) provides a mean infection number of 2086 sporozo-
ites per salivary gland (C. Maciel, unpublished data). Thus 
mosquitoes with numbers below that were considered as 
low infection. Restricting analysis to those mosquitoes a sig-
nificant 30.3 % reduction (p = 0.0186) in parasites recovered 
from salivary glands was observed when compared with 
wild-type controls (Fig. 4). The same analysis was performed 
using the mosquitoes showing the infection level above the 
threshold established, and there is no significant difference 
between pBac-PgpNT line P#1 and control mosquitoes. 
Moreover, there is no significant difference if the same anal-
ysis is performed with the TSR-based peptides Sin-PgRTSR, 
Sin-PfRTSR, Sin-PfpTSR (Additional file  3), showing that 
this event only occurs for NH2-terminus peptides.
Discussion
CSP represents 5–15 % of the total protein expressed in 
sporozoites and is highly immunogenic [28, 29]. These 
characteristics make CSP an excellent candidate for 
malaria vaccine development. RTS,S AS01, a recombi-
nant protein candidate malaria vaccine that targets the P. 
falciparum CSP is the first to reach phase three clinical 
testing and is partially effective against clinical disease in 
young African children up to 4  years after vaccination, 
according to final trial data [30]. Other important prop-
erties of CSP include its ligand-like interaction with mos-
quito salivary gland receptors and this makes it a target 
for disrupting parasite invasion in this tissue and thus 
blocking transmission. The results presented here are 
the first to show that endogenous production of peptides 
encompassing NH2-terminus of CSP protein using either 
a dsSindbis virus system or transgenic approach, inhibit 
sporozoite penetration into salivary gland using Ae. 
aegypti–P. gallinaceum model. Moreover this is the first 
report of a heterologous effect of the P. falciparum NH2-
terminus of CSP-peptide in the P. gallinaceum model.
Controversy accompanies the published conclusions of 
the roles of CSP Regions I and II in receptor-mediated sali-
vary gland recognition [11, 17–19]. The results presented 
here support the conclusion that the NH2-terminus (con-
taining Region I) has a role in salivary gland recognition 
but not TSR (with Region II) in P. gallinaceum infection 
in a model system. Previous reports of a role for Region II 
were based on experiments performed with P. berghei [19, 
31], however, the genetically-ablated parasites used were 
disabled in their gliding ability, and this makes it difficult 
to distinguish between disruption of a receptor-ligand 
interaction or the lack of motility as a cause of the reduced 
salivary gland infections. It also is possible that a mutation 
in Region II inhibits parasites egression from oocysts even 
though they produce the same numbers of oocyst sporo-
zoites [31]. Since the previous study did not measure the 
number of sporozoite in the haemocoel, it is possible that 
this is the cause of the impairment phenotype observed 
in both studies. Furthermore, once the NH2-terminus 
is removed from mutated parasites, the TSR domain is 
exposed, switching parasites from a migratory state to an 
adhesive state reducing the numbers of sporozoite capable 
of reaching and invading the salivary glands [11]. Thus, it is 
unlikely that the TSR + Region II is acting as a ligand for 
sporozoites for salivary gland invasion.
An evolutionarily-conserved role for the partial NH2-
terminus portion of CSP in salivary gland invasion is sup-
ported here, since it was observed that not only peptides 
from P. gallinaceum but also from P. falciparum are able 
to disrupt P. gallinaceum sporozoites penetration of Ae. 
aegypti salivary glands. Also, P. gallinaceum and P. fal-
ciparum are thought to be more closely-related than P. 
falciparum with other human malaria parasites [32–35]. 
Thus, information obtained with Ae. aegypti–P. gallina-
ceum model studies may be relevant to P. falciparum.
Transient expression of Sindbis-PgpNT resulted in a 
lower mRNA production than the other dsSindbis con-
structions and this most likely resulted in reduced pep-
tide production, which in turn would not be enough to 
interfere with sporozoite penetration of the salivary 
glands. Also, the non-specific amplification product was 
most likely due to virus instability in cell culture passages 
that could select viruses with different sequences or for 
those lacking the transgene [36].
The choice of the VgI promoter in the transgenesis con-
struct was based on its high level of expression and peak 
induction time (~24  h PBM). Previous work has shown 
its effectiveness in expressing heterologous proteins in Ae. 
aegypti transgenic lines [24, 27]. The signal peptide from 
the Ae. aegypti maltase-like I gene also was added to direct 
recombinant peptides into mosquito haemolymph [22].
Although all the elements chosen to generate the trans-
genic line were tested in previous reports, transgenic 
lines P#2 and F#8 did not express the transgene and this 
could be related to position effects, a phenomenon fre-
quently seen in mosquito transgenesis [37]. Furthermore, 
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F#8 had an abnormal fragment when amplified with 
specific primers, and a recombination event might have 
occurred disrupting the integrity of the transgene, so 
subsequent experiments were performed with line P#1 
that did not present these problems.
The initial analysis of parasite challenges of the pBac-
PgpNT line P#1 did not reveal a statistically-significant 
difference for P. gallinaceum sporozoite in salivary glands 
between them and non-transgenic controls. Although this 
result first suggested the incapability of transgenic mos-
quitoes to block parasite entrance in the salivary gland, a 
more profound analysis of that initial outcome was per-
formed. Since ligand/parasite competition should be 
interfered by parasite excess binding to the salivary gland, 
it was defined a threshold (<2086 sporozoites/salivary 
gland) to determine mosquitoes with low infection levels 
and a significant reduction in parasites recovered from 
salivary glands was observed between pBac-PgpNT line 
P#1 and control mosquitoes below the threshold, but not 
above (Additional file 3). Therefore, if the number of par-
asites is not in excess (saturation), it is possible to block 
the receptors thus inhibiting sporozoite salivary gland 
invasion, on the other hand, if the number of produced 
sporozoites is high, they will be able to overcome the 
blockade and penetrate the salivary gland. Moreover, the 
mosquitoes expressing TSR-based peptides Sin-PgRTSR, 
Sin-PfRTSR, Sin-PfpTSR were unable to generate signifi-
cant difference compared to control even if a threshold is 
established (Additional file 4) reinforcing the results pre-
sented by the second analysis of pBac-PgpNT line P#1.
The reduction (~30 %) of sporozoites invading salivary 
glands in the presence of peptides based on NH2-termi-
nus of CSP from either P. gallinaceum or P. falciparum in 
Ae. aegypti is lower than that observed (60–80  %) when 
A. stephensi were injected with synthetic peptides from P. 
falciparum and infected by P. berghei [18]. It is likely that 
the amounts of recombinant peptides produced by both 
dsSindbis virus and the transgene were lower than the 
amount injected in that study, and this is reflected in the 
blocking efficiency like stated previously. It was reasoned 
that because codon optimization is crucial for heterolo-
gous expression of CSP in transgenes in Anopheles gam-
biae [38], it might also be crucial in Ae. aegypti. Also, CSP 
is not the only protein described that could promote sali-
vary gland invasion [5, 6] and, therefore, complete inhibi-
tion may not be possible with a single class of peptides.
Recent technological advances in cellular and molecu-
lar biology, genetics and bioinformatics, have enabled the 
development of a transgenic A. stephensi transgenic lines 
that block the progression of the P. falciparum cycle ren-
dering salivary glands free of sporozoites [39]. This trans-
genic line is a groundbreaking tool towards an innovative, 
population modification method to control vector-borne 
diseases. However, human malaria parasites can be trans-
mitted by a ~465 formally recognized Anopheles species 
and ~41 are considered to be dominant vector species/
species complexes, capable of transmitting malaria at a 
level of major concern to public health [40]. Thus, fur-
ther studies on the biology of different vectors and host-
pathogen interactions are needed to provide a broad 
spectrum of control possibilities that include all mosqui-
toes-parasites combinations.
Conclusions
The interference of invasion of Ae. aegypti salivary gland 
by sporozoites achieved by endogenously-expressed 
peptides represents a step forward in understanding 
this complex stage in the parasite cycle. Together with 
previous studies, the data presented here indicate that 
peptides endogenously expressed from CSP partial NH2-
terminus are able to compete for receptors in the salivary 
gland and disrupt the sporozoite/salivary gland interac-
tion. Also, the fact that this portion of the protein from 
either the avian and human parasite is capable of mediat-
ing this recognition supports an evolutionarily conserved 
role between these parasites. The blocking effect of CSP 
recombinant peptides make them candidates that could 
be used to interfere with the parasite-salivary gland inter-
action and thus reduce sporozoite transmission.
Additional files
Additional file 1. Primers sequences used for PCR and RT‑PCR.
Additional file 2. Schematic representation of cloning into pTE/3 2 J 
plasmid (dsSindbis virus) and piggyBac[3Xp3‑EGFP] transgenesis plasmid. 
The nucleotide sequence encoding recombinant peptides was inserted 
into pTE/3 2 J dsSindbis vector using the XbaI restriction enzyme. Abbre‑
viations: SP6: Sindbis Promoter sequence; NSP 1, 2, 3, 4; Nonstructural 
viral protein; C: capsid; PE2: Envelope protein 2; Mal: Ae. aegypti encoding 
the secretory signal peptide (Mal I signal peptide); CSP‑PEP: correspond 
to pNH2‑T, RTSR and pTSR constructs; 3′UTR: dsSindbis virus untranslated 
region. (B) The Mal‑PgpNT fragment was reamplified and inserted into 
pSLfa[AeVg] and flanked by Ae. aegypti vitellogenin promoter (AeVg) and 
the SV40 polyadenylation sequence (SV40). (C) The [AeVg‑PgpNT‑SV40] 
transgene was inserted into a vector plasmid composed of the coding 
sequences of the EGFP gene to provide a visible transformation marker 
driving by three copies of the Pax3 (3xP3) promoter. Arrows (LH and RH) 
are the terminal inverted repeats of the piggyBac transposable element.
Additional file 3. Analysis of Plasmodium gallinaceum infection above 
the threshold (<2086 sporozoites/salivary gland) in pBac[3XP3‑eGFP‑
AeVg‑PgpNT] transgenic mosquitoes. Solid circles (wild‑type) and squares 
(transgenic pBac‑PgpNT P#1) represent individual mosquitoes with 
sporozoites detected in their salivary glands above the threshold of 2086 
sporozoites per salivary gland. The horizontal bars represent the median. A 
p value of <0.05 was considered statistically significant.
Additional file 4. Analysis of Plasmodium gallinaceum low levels infec‑
tion in dsSindbis infected and control mosquitoes. Solid circles (control 
Sin‑EGFP) and squares (Sin‑PfpNT, Sin‑PgRTSR, Sin‑PfRTSR, Sin‑PfpTSR) rep‑
resent individual mosquitoes with sporozoites detected in their salivary 
glands below the threshold of 2086 sporozoites per salivary gland. The 
horizontal bars represent the median. A p value of <0.05 was considered 
statistically significant.
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